
Investor relations
Company profile
SDS Optic S.A. develops innovative products for medical diagnostics. The flagship project of SDS Optic S.A. is inPROBE, a fiber-optic microsensor for oncology diagnostics.

Investor's calendar
Schedule of periodic report publications in 2025:
Quarterly report for Q4 2024 – February 14, 2025
Quarterly report for Q1-2025 – May 15, 2025
Quarterly report for Q2-2025 – August 14, 2025
Quarterly report for Q3-2025 – November 14, 2025
Annual report for 2024 – May 28, 2025

Contact for investors
Karol Maryniowski
Marketing, Communications and IR Manager
+48 81 501 94 63ir@sdsoptic.comFrequently asked questionsStock quote
The company has been listed on the NewConnect market of the Warsaw Stock Exchange since March 15, 2022
Sector: medical equipment and supplies
ISIN: PLSDSO00013
Ticker: SDS
Learn more
Shareholder structure
based on the information held by the Company as of the date of publication of the most recent periodic report.

SDS Optonic Sp. z o.o. is a subsidiary of Mr. Marcin Staniszewski, CEO of SDS Optic S.A., who, together with his spouse and the financial shareholders of SDS Optonic Sp. z o.o., as at the date of publication of this report, jointly hold 2,498,160 shares in the Company, representing 42.10% of the Company’s share capital. These shares entitle the holders to exercise 2,498,160 votes at the General Meeting of the Issuer, corresponding to 42.10% of the total voting rights in the Company. Pursuant to the provisions of the shareholders’ agreement of SDS Optonic sp. z o.o., concluded on 18 June 2021 and described in Current Report ESPI No. 3/2022 dated 16 February 2022, Mr. Marcin Staniszewski is entitled to a total of 1,234,935 shares in the Issuer, representing 20.81% of the Company’s share capital, while the remaining shareholders of SDS Optonic sp. z o.o. are entitled to 1,147,825 shares in the Issuer, representing 19.35% of the Company’s share capital.

SDS Optic Group Capital Structure
As of the end of December 2024, SDS Optic S.A. is the parent company of two subsidiaries, FiBioMed Sp. z o.o. and SDS Optic Inc., in which it holds majority stakes
Authorized Advisor and Market Animator
Authorized Advisor

Navigator Capital S.A.
18 Twarda Street, Warsawbiuro@navigatorcapital.plhttps://navigatorcapital.pl/+48 22 630 83 33We Care About Your Privacy
SDS Optic S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.